Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Walsh

Showing results (1471-1480 of 1,853) with videos related to

Pageof 186
Sort By:
Annals of Internal Medicine|April 28, 2025
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)Sharon A Riddler, Zoe Moodie, Jesse Clark, et al.
The New England Journal of Medicine|July 2, 2021
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin AmyloidosisJulian D Gillmore, Ed Gane, Jorg Taubel, et al.
Frontiers in Physiology|March 16, 2023
SHock-INduced Endotheliopathy (SHINE): A mechanistic justification for viscoelastography-guided resuscitation of traumatic and non-traumatic shockConnor M Bunch, Eric Chang, Ernest E Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2020
Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrierOscar A Marcos-Contreras, Colin F Greineder, Raisa Yu Kiseleva, et al.
Kidney International|May 11, 2020
Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathyVicky Brocklebank, Gurinder Kumar, Alexander J Howie, et al.
BMC Surgery|April 15, 2024
Observed rates of surgical instrument errors point to visualization tasks as being a critically vulnerable point in sterile processing and a significant cause of lost chargeable OR minutesPeter F Nichol, Mark J Saari, Natalia Navas, et al.
The Journal of Infectious Diseases|August 29, 2014
Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humansLindsey R Baden, Jinyan Liu, Hualin Li, et al.
Nature Reviews. Microbiology|November 4, 2011
Tackling antibiotic resistanceKaren Bush, Patrice Courvalin, Gautam Dantas, et al.
PLOS Global Public Health|April 11, 2025
ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boostLeigh H Fisher, Erica Lazarus, Chenchen Yu, et al.
JAMA Network Open|January 23, 2023
Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine TrialsAlfredo J Mena Lora, Jessica E Long, Yunda Huang, et al.
Pageof 186

Showing results (1471-1480 of 1,853) with videos related to

Sort By:
Pageof 186
Annals of Internal Medicine|April 28, 2025
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)Sharon A Riddler, Zoe Moodie, Jesse Clark, et al.
The New England Journal of Medicine|July 2, 2021
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin AmyloidosisJulian D Gillmore, Ed Gane, Jorg Taubel, et al.
Frontiers in Physiology|March 16, 2023
SHock-INduced Endotheliopathy (SHINE): A mechanistic justification for viscoelastography-guided resuscitation of traumatic and non-traumatic shockConnor M Bunch, Eric Chang, Ernest E Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2020
Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrierOscar A Marcos-Contreras, Colin F Greineder, Raisa Yu Kiseleva, et al.
Kidney International|May 11, 2020
Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathyVicky Brocklebank, Gurinder Kumar, Alexander J Howie, et al.
BMC Surgery|April 15, 2024
Observed rates of surgical instrument errors point to visualization tasks as being a critically vulnerable point in sterile processing and a significant cause of lost chargeable OR minutesPeter F Nichol, Mark J Saari, Natalia Navas, et al.
The Journal of Infectious Diseases|August 29, 2014
Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humansLindsey R Baden, Jinyan Liu, Hualin Li, et al.
Nature Reviews. Microbiology|November 4, 2011
Tackling antibiotic resistanceKaren Bush, Patrice Courvalin, Gautam Dantas, et al.
PLOS Global Public Health|April 11, 2025
ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boostLeigh H Fisher, Erica Lazarus, Chenchen Yu, et al.
JAMA Network Open|January 23, 2023
Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine TrialsAlfredo J Mena Lora, Jessica E Long, Yunda Huang, et al.
Pageof 186